We have a dedicated program manager coordinating the various subgroups to ensure timely execution, foster crosstalk, and promote scientific and public engagement.
Stefan Irion, MD
Memorial Sloan Kettering
Information for Patients
Our research has laid the foundation for new therapy under investigation for Parkinson’s disease. However, for the therapy to be realized, every step must be taken with caution, and conclusions must be scrutinized from every angle.
We have assembled a team of experts who will do just that, and an external oversight committee will help us make the right decisions. One step in the wrong direction could jeopardize the project. It is thus our responsibility to follow a clear path and align our protocols with the current state of research and the regulatory environment. This means that right now we cannot accept requests for trial participation, counseling, or other services related to this project.